China has granted conditional approval to two homegrown COVID-19 oral pills, the National Medical Products Administration said on Jan 29.
From Sunday, China starts managing COVID-19 with measures designed for combating Class B infectious diseases, instead of Class A infectious diseases.
Seniors and people identified as being at higher risk from COVID-19 are now eligible for a second vaccine booster shot, according to a notice issued on Dec 14.
Shanghai began to utilize up to 2,600 community-level fever clinics starting today to tackle the swelling demands for medical treatments in the city's upgraded efforts to respond to the COVID-19 pandemic.
Major adjustments have been made to China's COVID-19 control policies. Below are some of the key changes, to help you keep up to date.
Shanghai announced on Tuesday that it would provide an inhaled version of CanSino Biologics' injected COVID-19 vaccine as a booster dose for people age 18 and above.
The largest central quarantine site for COVID-19 cases with mild symptoms and asymptomatic infections in Shanghai was put into full operation on Tuesday night.
The production of a single-shot COVID-19 vaccine made by CanSino SPH Biologics Inc was launched in Shanghai on Thursday.